Related Experiment Video

Updated: May 10, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Possible new modifications for the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis

Carmen Tur, Xavier Montalban

    Multiple Sclerosis (Houndmills, Basingstoke, England)
    |July 3, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
    11:35

    The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

    Published on: June 30, 2014

    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
    09:41

    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

    Published on: July 19, 2019

    Related Experiment Videos

    Last Updated: May 10, 2026

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
    08:51

    Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

    Published on: February 19, 2021

    The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
    11:35

    The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

    Published on: June 30, 2014

    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
    09:41

    Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

    Published on: July 19, 2019

    Related Concept Videos

    Multiple Sclerosis l: Introduction01:19

    Multiple Sclerosis l: Introduction

    Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

    Articles linked to this work by shared authors, journal, and citation graph.

    Serum Glial-Related Biomarkers Show Distinct Contributions to Radiologic and Clinical Outcomes in Early Multiple Sclerosis.

    Neurology(R) neuroimmunology & neuroinflammation·2026

    Age and treatment class modify inflammatory risk after disease-modifying therapy discontinuation in older people with MS.

    Journal of neurology, neurosurgery, and psychiatry·2026

    Dorsolateral nigral hyperintensity in idiopathic REM sleep behavior disorder: a systematic review and meta-analysis.

    Sleep medicine reviews·2026

    "Low-Positive" MOG-IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis.

    Annals of clinical and translational neurology·2026

    A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2026

    Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores.

    Neurology·2026

    Lymphocytosis as a biomarker for natalizumab treatment response in multiple sclerosis: The link with anti-drug antibodies.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2026

    Increased autoimmune disease burden before multiple sclerosis and neuromyelitis optica spectrum disorder diagnosis: A nationwide Korean cohort study.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2026

    Who declines neurocognitive testing? A cross-sectional study in people with multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2026

    Validation of generative artificial intelligence techniques for synthetic data generation in multiple sclerosis research: A comparison with real-world evidence from the Italian multiple sclerosis registry.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2026

    Survivor bias and disease progression in observational cohorts in multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2026

    How well do junior neurology residents recognize multiple sclerosis? Analysis of the "Close the Loop" resident clinical acumen project.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2026

    Routine Forearm Cast Splitting in Pediatric Patients Following Closed Reduction.

    Cureus·2026

    Topical oxybutynin antiperspirant for axillary hyperhidrosis: a phase IIb PROBE design clinical trial (TODAY trial).

    Jornal vascular brasileiro·2026

    Hydrolysis of Lignin α‑O‑4 Model Compounds Using Strong Acid Catalyst in Water.

    ACS omega·2026

    Tuning σ‑Hole Chalcogen···Nitrogen Bonding Between C2F4Ch2 and Nitrogen Bases: Dual Modulation by Chalcogen Atomic Size and Nitrogen Hybridization (Ch = S, Se, Te, Po).

    ACS omega·2026

    Photocatalytic Isomerization of Stilbenes via Molecular Recognition With a Dual-Function η6-Arene Catalyst.

    Angewandte Chemie (International ed. in English)·2026

    Visible-Light Photoredox-Catalyzed Sp3 C-H Sulfonylation of Oxime Ester.

    The Journal of organic chemistry·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us